XML 46 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Net Cash Provided by (Used in) Operating Activities [Abstract]      
Net income $ 6,230,000,000 $ 6,828,000,000 $ 1,588,000,000
Less: Net income attributable to the noncontrolling interest 87,000,000 63,000,000 43,000,000
Net income attributable to Honeywell 6,143,000,000 6,765,000,000 1,545,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities [Abstract]      
Depreciation 673,000,000 721,000,000 717,000,000
Amortization 415,000,000 395,000,000 398,000,000
{Gain) loss on sale of non-strategic businesses and assets 1,000,000 0 7,000,000
Repositioning and other charges 546,000,000 1,091,000,000 973,000,000
Net payments for repositioning and other charges (376,000,000) (652,000,000) (628,000,000)
Pension and other postretirement income (516,000,000) (987,000,000) (647,000,000)
Pension and other postretirement benefit payments (78,000,000) (80,000,000) (106,000,000)
Stock compensation expense 153,000,000 175,000,000 176,000,000
Deferred income taxes 179,000,000 (586,000,000) 2,452,000,000
Other (287,000,000) (694,000,000) 1,642,000,000
Changes in assets and liabilities, net of the effects of acquisitions and divestitures: [Abstract]      
Accounts receivable 11,000,000 (236,000,000) (682,000,000)
Inventories (100,000,000) (503,000,000) (259,000,000)
Other current assets (430,000,000) 218,000,000 (568,000,000)
Accounts payable 118,000,000 733,000,000 924,000,000
Accrued liabilities 445,000,000 74,000,000 22,000,000
Net cash provided by (used for) operating activities 6,897,000,000 6,434,000,000 5,966,000,000
Cash flows from investing activities: [Abstract]      
Expenditures for property, plant and equipment (839,000,000) (828,000,000) (1,031,000,000)
Proceeds from disposals of property, plant and equipment 43,000,000 15,000,000 86,000,000
Increase in investments (4,253,000,000) (4,059,000,000) (6,743,000,000)
Decrease in investments 4,464,000,000 6,032,000,000 4,414,000,000
Cash paid for acquisitions, net of cash acquired (50,000,000) (535,000,000) (82,000,000)
Other 102,000,000 402,000,000 (218,000,000)
Net cash provided by (used for) investing activities (533,000,000) 1,027,000,000 (3,574,000,000)
Cash flows from financing activities: [Abstract]      
Proceeds from issuance of commercial paper and other short-term borrowings 14,199,000,000 23,891,000,000 13,701,000,000
Payments of commercial paper and other short-term borrowings (14,199,000,000) (24,095,000,000) (13,532,000,000)
Proceeds from issuance of common stock 498,000,000 267,000,000 520,000,000
Proceeds from issuance of long-term debt 2,726,000,000 27,000,000 1,238,000,000
Payments of long-term debt (2,903,000,000) (1,330,000,000) (292,000,000)
Repurchases of common stock (4,400,000,000) (4,000,000,000) (2,889,000,000)
Cash dividends paid (2,442,000,000) (2,272,000,000) (2,119,000,000)
Pre-separation funding 0 2,801,000,000 0
Spin-off cash 0 (179,000,000) 0
Other (79,000,000) (142,000,000) (143,000,000)
Net cash provided by (used for) financing activities (6,600,000,000) (5,032,000,000) (3,516,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents 16,000,000 (201,000,000) 340,000,000
Net increase (decrease) in cash and cash equivalents (220,000,000) 2,228,000,000 (784,000,000)
Cash and cash equivalents at beginning of period 9,287,000,000 7,059,000,000 7,843,000,000
Cash and cash equivalents at end of period $ 9,067,000,000 $ 9,287,000,000 $ 7,059,000,000